This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Huntington's disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Huntington's disease (also known as Huntington's chorea) is a hereditary disease that is marked by chronic, progressive chorea and marked mental deterioration in middle life, usually in the fourth decade.

The disease has a prevalence of about 1 in 20,000 in the UK. It is inherited as an autosomal dominant trait with full penetrance (meaning that individuals born to a parent with Huntington disease have a 50% chance of developing the disease). The family history of the disease is often concealed.

The gene responsible for this condition resides on chromosome 4. Predictive DNA testing of at risk relatives of sufferers reduces anxiety, whatever the test outcome.

Symptoms of Huntington disease typically first appear between ages 30 and 50 years and include

  • motor function disturbances: including involuntary, jerking or writhing, dance-like movements (chorea) of the face, torso, and limbs; involuntary muscle contractions (dystonia); impaired eye movements; and slurred speech
  • cognitive disturbabces: including disturbances in planning, processing speed, memory, and judgment
  • mood disturbances: including depression, anxiety, apathy, agitation, and psychosis

Reference:

  • Marcus R. What Is Huntington Disease? JAMA. 2023;330(10):1014. doi:10.1001/jama.2023.13024

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.